Form 4 for NEO NEOGENOMICS INC
Accepted 2025-11-28 00:00:00 ET · period of report 2025-11-25 · accession 0001628280-25-054270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-28 | 2025-11-25 | NEO | Olivo Alicia C | EVP, GC, Business Development | S - Sale+OE | $12.00 | -20.9K | 31.1K | -40% | -$251.0K |
| D | 2025-11-28 | 2025-11-25 | NEO | Olivo Alicia C | EVP, GC, Business Development | M - OptEx | $10.05 | +8,977 | 52.0K | +21% | +$90.2K |
| D | 2025-11-28 | 2025-11-25 | NEO | Olivo Alicia C | EVP, GC, Business Development | M - OptEx | $0.00 | -8,977 | 46.4K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | S | D | 20,916 | $12.00 | 31,083 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-25 | M | A | 8,977 | $10.05 | 51,999 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 8,977 | $0.00 | 46,355 | D | $10.05 · — to 2029-09-01 | 8,977 Common Stock | (F2) On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date. |